J & J ’ s Ethicon hit with $57m verdict in pelvic mesh case

Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon has been hit with a $57.1 million verdict in a pelvic mesh case out of Pennsylvania, according to a report from The Inquirer. A jury in Philadelphia ordered the subsidiary to pay the damages to a woman who was left chronically incontinent and with chronic pain after being implanted with a defective pelvic mesh implant, according to the report. The plaintiff, Ella Ebaugh, received 2 Ethicon mesh implants which later eroded into her urethra, according to The Inquirer, and required 3 surgeries to remove the meshes. The damages awarded are greater than those won by plaintiffs in 4 previously tried cases in Philadelphia as part of a mass tort program for trials related to the implants. Previous victories included a $12.5 million award in December 2015, a $13.5 million award last February, a $20 million award this April and another $2.1 million to a Pennsylvania woman in June, according to the paper. Ethicon told The Inquirer that it plans to appeal the verdict. “We believe the evidence showed Ethicon’s TVT and TVT-Secur devices were properly designed, Ethicon acted appropriately and responsibly in the research, development and marketing of the products, and the products were not the cause of the plaintiff’s continuing medical problems,” Ethicon spokesperson Kristen Wallace told The Inquirer. The post J&J’s Ethicon hit with $57m verdict in pelvic mesh case appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Legal News Ethicon johnsonandjohnson Source Type: news